← Back to Search

Clinical Decision Support

Clinical Decision Support for Respiratory Infections

N/A

Waitlist Available

Led By Devin Mann

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients must have been seen at a participating clinic with a complaint of cough or sore throat

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, month 6, month 12

Awards & highlights

Study Summary

This trial found that using a new clinical prediction tool helped nurses more accurately prescribe antibiotics for patients with respiratory infections.

Who is the study for?

This trial is for patients aged 3-70 with sore throat and 18-70 with cough, seen at participating clinics. Nurses prescribing treatment must work at least half-time, be licensed, use the clinic's EHR system regularly, and see a sufficient number of patients to maintain skills.Check my eligibility

What is being tested?

The study tests an integrated clinical prediction tool in electronic health records (EHR) that helps nurses decide when antibiotics are needed for acute respiratory infections. It aims to ensure prescriptions are evidence-based.See study design

What are the potential side effects?

Since this trial involves a decision-support tool rather than medication or procedures, there aren't direct side effects like those associated with drugs or medical treatments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I visited a clinic for a cough or sore throat.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, month 6, month 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, month 6, month 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, month 6, month 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in number of Acute Respiratory Infection(ARI) encounters

Number of Participants Who Perceive the iCPR Tool as Useful.

Secondary outcome measures

Change in Job Satisfaction of RNs and physicians

Number of nurse triage encounters completed

Number of patients requiring repeat healthcare visits

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: iCPR groupExperimental Treatment1 Intervention

Clinic personnel (Providers and Nurses) will receive online training that includes: 1) an overview of the project; 2) iCPR workflows including triage; 3) CPR component review and risk categories; 4) history and physical examination components of the CPRs. The online training will be followed by in-person training to reinforce the online training and teach additional skills. In-person training sessions led by study team will last approximately 60 minutes, and consist of four basic components: 1) a review of the iCPR ARI protocol and tools; 2) on-screen walk-throughs of common scenarios employing the new tools; 3) physical examination technique practice with simulated patients; A 60-minute in-person follow-up nurse training will take place 4-6 weeks after implementation of the intervention.

Group II: Control no intervention groupActive Control1 Intervention

standard care will continue as usual.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor

1,367 Previous Clinical Trials

839,261 Total Patients Enrolled

National Institute of Allergy and Infectious Diseases (NIAID)NIH

3,268 Previous Clinical Trials

5,480,632 Total Patients Enrolled

Devin MannPrincipal InvestigatorNYU Langone

Media Library

iCPR system (Clinical Decision Support) Clinical Trial Eligibility Overview. Trial Name: NCT04255303 — N/A

Acute Respiratory Infection Research Study Groups: iCPR group, Control no intervention group

Acute Respiratory Infection Clinical Trial 2023: iCPR system Highlights & Side Effects. Trial Name: NCT04255303 — N/A

iCPR system (Clinical Decision Support) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04255303 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently any vacancies for participants of this clinical trial?

"Data on clinicaltrials.gov reveals that this medical trial, initially posted in February and last amended in June of 2022, is not at present looking for participants. Nevertheless, there are 815 other active studies currently recruiting patients."

Answered by AI

Are there abundant sites in this city where the experiment is being conducted?

"This trial is presently operational at 4 sites, which are positioned in New york, Great Neck and Salt Lake City alongside other nearby locales. It would be prudent to choose a site that's nearest you for the sake of reducing travel needs if accepted into this study."

Answered by AI

What objective is this experiment seeking to accomplish?

"The primary focus of this trial, evaluated over the span of 6 months, is to assess the alteration in Acute Respiratory Infection (ARI) encounters. Additionally, its secondary goals include measuring job satisfaction/burnout with interviews at baseline and intervals throughout the study; quantifying nurse triage encounters completed; as well as recording patients requiring repeat healthcare visits through extracted Electronic Health Record (EHR) data."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Decreasing Antibiotic Prescribing in Acute Respiratory Infections Through Nurse Driven Clinical Decision Support

2022. "Decreasing Antibiotic Prescribing in Acute Respiratory Infections Through Nurse Driven Clinical Decision Support". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04255303.

All > Rsv